Margie's work focuses on how to prevent unintentional injuries, particularly in resource-strapped countries.

While road injuries are the biggest issue, Margie's work also canvases other significant problems of drowning, burns and falls, and identifies interventions that could save lives. Her research looks at what works, specifically in developing countries. It will provide evidence on how to prevent injuries before they happen. But it will also hope to look at the post-crash phase, working with nurses – who are the mainstay of healthcare provision in developing countries – to provide optimum treatment management. In some developing countries, traumatic injuries account for up to 70%-80% of the caseloads in emergency rooms. If you can stop these injuries upstream, there are enormous gains for healthcare systems, both financially and in terms of workforce needs.

Representing The George Institute for Global Health and South Africa, Margie is a member of the Commonwealth Road Safety Initiative Expert Panel and together with colleagues from Kenya and Canada leads the data analysis for the reports being developed ahead of the 3rd Ministerial level meeting in Sweden in February 2020 and the CHOG meeting in Rwanda. She is also a member of the Academic Expert Group for this Ministerial meeting, a group responsible for making an independent and scientific assessment of the progress made during the Decade of Action for Road Safety. This report is now available here. The Academic Expert Group will also recommend a road safety strategy for the period 2020-2030. Margie is also Chair of the Global Advisory Board for the Malawi Road Safety Research and Implementation Unit at the University of Malawi.

Prior to working at The George Institute, she was a nurse and an epidemiologist. She worked in a hospital in Cape Town, South Africa for many years before moving to the National Trauma Research Programme at the South African Medical Research Council. After that she was at the World Health Organization for 17 years, coordinating the Unintentional Injury Prevention unit. 

Marino Festa is an Honorary Fellow in the Critical Care and Trauma Division of The George Institute. He is a senior staff specialist and co-lead for Kids Critical Care Research at The Children’s Hospital at Westmead (CHW) in Sydney.

He is a fellow of the College of Intensive Care Medicine and has completed a Doctor of Medicine (Research), Imperial College, London 2011. He represents CHW on the paediatric study group of the ANZICS Clinical Trial Group and is principal investigator for the SAFE EPIC global point prevalence study.

He has active research interests in the areas of paediatric fluid resuscitation, microvascular adaptation to shock, and human factors research in critically ill and simulated patients.

Prof. Mark Huffman, a Professorial Fellow at The George Institute for Global Health and Adjunct Professor at UNSW, is a globally recognized preventive cardiologist with over a decade of experience in cardiovascular dissemination and implementation research. He is a Professor of Medicine (Cardiology) and Co-Director of the Global Health Center at Washington University in St. Louis and Adjunct Professor of Preventive Medicine at Northwestern University.

He is a Fellow of the American Heart Association and the American College of Cardiology and was recognised as an Emerging Leader in Health and Medicine through the National Academy of Medicine. He is a standing member of the NIH Science of Implementation for Health and Health Care study section.

He co-created the World Heart Federation’s flagship Emerging Leaders program, which has trained >200 early-to-mid-career professionals from >50 countries in implementation research. Prof. Huffman has taught graduate-level courses, co-directed the NIH/Fogarty-funded global health fellows’ research training program, and mentored undergraduate, graduate, postgraduate, and early-stage investigator trainees in implementation research.

Mark Woodward is Chair of Statistics, Epidemiology and Women’s Health at Imperial College London, Professor of Medical Statistics at the University of New South Wales, Senior Visiting Research Fellow of Green Templeton College, Oxford University and Honorary Professor at the universities of Dundee, Mahidol (Thailand) and the West Indies.

Mark is the author of over 850 peer-reviewed publications, 20 of which have over 1000 citations, and two text-books on statistical methods in medical research. He has been named amongst the world’s most citied researchers in each year since the current ranking system started in 2014, with a H-index of over 160.

Mark has undertaken 24 development aid missions in Africa and Asia and served on the governing councils of both the Institute of Statisticians and the Royal Statistical Society (RSS). His previous professorships have been at the University of Oxford, New York University, the University of Sydney, and as an adjunct professor at Johns Hopkins University.

Marna van Zyl is Legal Director at The George Institute.

Martin is Professorial Fellow at the George Institute, Head of the South Western Sydney Campus for the Faculty of Medicine & Health at UNSW, and a clinical nephrologist at Liverpool Hospital.

He has worked extensively within the ANZ Society of Nephrology in renal guidelines, clinical policy and research.

Martin’s research interests include large scale clinical trials to explore ways to improve the outcomes of patients with kidney disease (esp in the setting of acute kidney injury), measurement of health systems and applying research evidence into clinical practice.

Dr Meena Thuraisingham is Founder and Principal at BoardQ and TalentInvest. She is also a Non-Executive Director of the Shared Value Project and Linden Art Gallery.

Meena has previously held executive roles at ANZ, including Global Head of Leadership and Talent and Head of Human Resources, Corporate & Institutional Bank. She has also held senior consultant roles with two global consulting firms.

Meena joined the Board in January 2018 and is a Member of the Risk Committee.

A/Professor Meg Jardine is a Honorary Professorial Fellow at The George Institute for Global Health.

Her research interests centre on preventing the progression and complications of kidney disease and diabetes. She has a particular interest in using innovative trial designs to better generate evidence to improve outcomes. Dr Jardine leads the RESOLVE and BEAT-Calci trials and was the Global Scientific Lead of the CREDENCE study and CI of the ACTIVE and FINESSE trials. Her advocacy for kidney disease is pursued through memberships of the Board of the Kidney Health Initiative (KHI), the Executive Committee of the international KDIGO guidelines group and the International Society of Nephrology Advancing Clinical Trials (ISN-ACTS) core committee. 

Meg Jardine is a practising physician and nephrologist at Concord Repatriation General Hospital

Dr Menglu Ouyang is a research fellow at The George Insititute for Global Health and Conjoint Lecturer at UNSW. Her research field is in stroke, including acute care, clinical management, health system and implementation science. She has extensive experience in secondary analysis in large international clinical trials and implementation research. Her research contributes to filling the knowledge gap in stroke clinical guidelines development, informs implementation strategies and supports promoting the care embedded in existing processes in low- and middle-income countries.

She is the leading investigator for the process evaluation alongside the large international trials funded by MRC and NHMRC, to explore the feasibility, acceptability and implementation of evidence-based care. She also chairs the monthly Process Evaluation/Health System Research Seminar at The George Institute. She is in the UNSW Cardiac, Vascular, Metabolic Medicine Early Career Researcher Committee and the editor board of Cerebrovascular Diseases and Frontiers Public Health.

Mercian Daniel is Senior Research Fellow in, Mental Health Program at George Institute India. He has done his M.Phil. from Central Institute of Psychiatry, Ranchi and his Ph.D. from JNU, New Delhi.

He has over 15 years of research and program implementation working in different capacities at Deptt. of Psychiatry, Ram Manohar Lohia Hospital, New Delhi; IIMC, Dept. of Communication Research, New Delhi; Praxis, New Delhi and Save the Children, Calcutta. More recently, he was with PHFI working in reproductive health and urban health governance projects. He has also taught postgraduate students at Delhi School of Social Work, New Delhi and prepared MSW curriculum for St. Xavier’s University, Kolkata.

His research interest lies in evaluating the impact of different forms of anti-stigma campaigns in mental health, first-person accounts of living with mental illness and its contribution to policy narratives, the social determinants and gradient in mental disorders.

Min Jun is Scientia Associate Professor and Program Lead at the George Institute for Global Health, Faculty of Medicine, UNSW Sydney.

Min leads a program of research focused on understanding the impact of clinical management strategies in people with kidney disease and its related complications. He has developed and leads international projects using large clinical trial and real-world, population based data sources.

Min holds a PhD (2012) and MScMed(ClinEpi) in clinical epidemiology from the University of Sydney, and a MSc(by research) and BSc(Hon) from UNSW Sydney. He was previously an NHMRC Early Career Fellow (2013-2016) based in Canada (University of Calgary), co-funded by two additional competitive federal/provincial Canadian fellowships (CIHR/AIHS). Min's research track record includes >100 publications (including in top-ranked journals e.g. BMJ, Lancet, JACC), >$5.1M in research funding from top-level funding agencies (e.g. NHMRC). To date, 72% of his work is published in top 10% journals worldwide, has been cited >4500 times including in some 24 international clinical practice guidelines across various fields.

Min is actively involved in mentoring, training and supervising research students and fellows. He currently serves as Associate Editor (Global Health) for Kidney and Blood Pressure Research and has been involved in the development of clinical practice guidelines for the care of patients with kidney disease in Australia and internationally.